JP2021528096A5 - - Google Patents
Info
- Publication number
- JP2021528096A5 JP2021528096A5 JP2020573481A JP2020573481A JP2021528096A5 JP 2021528096 A5 JP2021528096 A5 JP 2021528096A5 JP 2020573481 A JP2020573481 A JP 2020573481A JP 2020573481 A JP2020573481 A JP 2020573481A JP 2021528096 A5 JP2021528096 A5 JP 2021528096A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- exosome
- lipid
- modified rna
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024034020A JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862691348P | 2018-06-28 | 2018-06-28 | |
| US62/691,348 | 2018-06-28 | ||
| PCT/EP2019/067232 WO2020002540A1 (en) | 2018-06-28 | 2019-06-27 | Exosome extracellular vesicles and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024034020A Division JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021528096A JP2021528096A (ja) | 2021-10-21 |
| JP2021528096A5 true JP2021528096A5 (cg-RX-API-DMAC7.html) | 2022-07-04 |
| JP7897689B2 JP7897689B2 (ja) | 2026-07-30 |
Family
ID=67139730
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573481A Active JP7897689B2 (ja) | 2018-06-28 | 2019-06-27 | エキソソーム細胞外小胞及びその使用方法 |
| JP2024034020A Withdrawn JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024034020A Withdrawn JP2024081661A (ja) | 2018-06-28 | 2024-03-06 | エキソソーム細胞外小胞及びその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12109310B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3813798A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7897689B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112543629A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020002540A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| TW202220637A (zh) * | 2020-08-06 | 2022-06-01 | 美商現代公司 | 製備脂質奈米顆粒之方法 |
| JP7633787B2 (ja) * | 2020-09-23 | 2025-02-20 | 三洋化成工業株式会社 | 細胞外小胞の製造方法 |
| MX2023004371A (es) | 2020-10-14 | 2023-07-26 | George Mason Res Foundation Inc | Lípidos ionizables, y métodos de fabricación y uso de los mismos. |
| EP4387657A4 (en) * | 2021-08-17 | 2025-05-21 | Monash University | Lipid nanoparticle formulations |
| WO2023178500A1 (en) * | 2022-03-22 | 2023-09-28 | Beijing Theraxyte Bioscience Co. Ltd. | Therapeutic vesicles and methods of processing the same |
| CN114848608B (zh) * | 2022-05-17 | 2024-01-30 | 东南大学 | 一种蛋白或多肽递送载体及其制备方法与应用 |
| CN115887758B (zh) * | 2022-11-15 | 2024-01-26 | 西南交通大学 | 负载外泌体促进糖尿病创面修复的共聚水凝胶 |
| CN117679354B (zh) * | 2024-02-04 | 2024-05-28 | 知想(山东)医疗科技有限公司 | 金花茶外泌体制剂及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2419144T (pt) | 2009-04-17 | 2019-09-16 | Univ Oxford Innovation Ltd | Composição para a administração de material genético |
| JP2010285426A (ja) | 2009-05-11 | 2010-12-24 | National Cancer Center | 核酸導入方法 |
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| CN103068980B (zh) | 2010-08-02 | 2017-04-05 | 瑟纳治疗公司 | 使用短干扰核酸(siNA)的RNA干扰介导的联蛋白(钙粘蛋白关联蛋白质),β1(CTNNB1)基因表达的抑制 |
| US8691750B2 (en) | 2011-05-17 | 2014-04-08 | Axolabs Gmbh | Lipids and compositions for intracellular delivery of biologically active compounds |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| EA037503B1 (ru) * | 2014-01-21 | 2021-04-05 | Анджариум Байосайенсиз Аг | Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| EP3247328B1 (en) * | 2015-01-21 | 2026-01-07 | Genevant Sciences Gmbh | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
| EP3500244B1 (en) * | 2016-08-22 | 2026-07-08 | Lonza Sales AG | Methods of suppressing delivery of exosomes to liver and spleen |
| EP3292861A1 (en) | 2016-09-13 | 2018-03-14 | Centre National De La Recherche Scientifique (Cnrs) | An in vitro method for obtaining a biohybrid vector |
-
2019
- 2019-06-27 CN CN201980042830.1A patent/CN112543629A/zh active Pending
- 2019-06-27 EP EP19735277.6A patent/EP3813798A1/en active Pending
- 2019-06-27 US US16/972,190 patent/US12109310B2/en active Active
- 2019-06-27 JP JP2020573481A patent/JP7897689B2/ja active Active
- 2019-06-27 WO PCT/EP2019/067232 patent/WO2020002540A1/en not_active Ceased
-
2024
- 2024-03-06 JP JP2024034020A patent/JP2024081661A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7635131B2 (ja) | 脂質ナノ粒子の調製方法 | |
| Min et al. | BDNF-enriched small extracellular vesicles protect against noise-induced hearing loss in mice | |
| TWI825602B (zh) | 用於細胞內遞送治療劑之化合物及組合物 | |
| CN108368028B (zh) | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 | |
| CN114269360A (zh) | 用于治疗递送的平台、组合物和方法 | |
| Zeng et al. | Micro Trojan horses: Engineering extracellular vesicles crossing biological barriers for drug delivery | |
| CN118647601A (zh) | 用于脂质纳米颗粒的氟代阳离子脂质 | |
| JP2020532528A (ja) | 脂質ナノ粒子の生成方法 | |
| US20240148794A1 (en) | Lnp compositions comprising payloads for in vivo therapy | |
| CN116693411A (zh) | 用于递送核酸的新型羰基脂质和脂质纳米颗粒制剂 | |
| TW201534578A (zh) | 新穎脂質 | |
| EP3107549B1 (en) | Anionic polyplexes for use in the delivery of nucleic acids | |
| Liu et al. | Distinct molecular properties and functions of small EV subpopulations isolated from human umbilical cord MSCs using tangential flow filtration combined with size exclusion chromatography | |
| Shao et al. | Extracellular vesicles participate in macrophage-involved immune responses under liver diseases | |
| CN119654141A (zh) | 脂质纳米颗粒的组合物 | |
| WO2023036148A1 (zh) | 一类阳离子脂质化合物及其应用 | |
| EP4424670A1 (en) | Lipid compound and lipid nanoparticle composition | |
| EP3675871A1 (en) | Compositions and methods for the treatment of fibrotic diseases | |
| EP4529928A2 (en) | Compositions, methods and uses of messenger rna | |
| JP2025533111A (ja) | Rnaコンストラクト及びその使用 | |
| CN110898231B (zh) | 一种功能化拉洛他赛脂质体及其制备方法与应用 | |
| CN119330848A (zh) | 用于递送的脂质化合物及脂质纳米颗粒 | |
| KR20200136430A (ko) | 점액 층을 가로지르는 마이크로/나노입자의 전위를 향상시키기 위한 알지네이트 올리고머의 용도 | |
| TW201726614A (zh) | 作為陽離子性脂質之化合物 | |
| CN111154755B (zh) | 一种双链寡核苷酸dna及其应用 |